BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 287 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q4 2021. The put-call ratio across all filers is 1.02 and the average weighting 0.8%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $125,572,000 | +3.7% | 830,668 | -0.0% | 0.13% | +12.4% |
Q2 2022 | $121,052,000 | -11.4% | 830,776 | -27.9% | 0.11% | +9.7% |
Q1 2022 | $136,572,000 | +13.6% | 1,151,829 | +32.0% | 0.10% | +25.6% |
Q4 2021 | $120,249,000 | -0.7% | 872,570 | +0.1% | 0.08% | -4.7% |
Q3 2021 | $121,098,000 | +42.7% | 871,776 | -0.3% | 0.09% | +45.8% |
Q2 2021 | $84,878,000 | +64.0% | 874,314 | +15.4% | 0.06% | +51.3% |
Q1 2021 | $51,764,000 | +13.2% | 757,340 | +41.9% | 0.04% | +11.4% |
Q4 2020 | $45,738,000 | +90.6% | 533,631 | +44.6% | 0.04% | +66.7% |
Q3 2020 | $23,999,000 | +17.5% | 369,156 | +32.2% | 0.02% | +16.7% |
Q2 2020 | $20,423,000 | – | 279,345 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Knoll Capital Management, LLC | 490,422 | $12,755,876 | 13.24% |
FNY Investment Advisers, LLC | 30 | $0 | 0.00% |